- Cemiplimab in patients with metastatic of locally advanced cutaneous squamous-cell carcinoma2020 | Faculty of Medicine in Hradec Králové
- Immunotherapy for Bladder Cancer2017 | First Faculty of Medicine
- Nivolumab in the treatment of metastatic melanoma2015 | Publication without faculty affiliation
- Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma2017 | Faculty of Medicine in Pilsen
- Advances in the treatment of metastatic melanoma2013 | Publication without faculty affiliation
- Immuno-oncological treatment of melanoma2014 | Publication without faculty affiliation
- Immunotherapy of renal cell carcinoma2018 | First Faculty of Medicine
- Pembrolizumab in therapy of metastatic melanoma2016 | Publication without faculty affiliation
- Immunotherapy for metastatic melanoma2015 | Publication without faculty affiliation
- Immunotherapy of malignant melanoma2015 | Publication without faculty affiliation
- Pseudoprogrese imitující kostní metastázu u pacienta léčeného nivolumabem pro metastazující melanom2019 | First Faculty of Medicine
- Is anticancer immunotherapy break-trough in lung cancer therapy?2019 | First Faculty of Medicine
- Is anticancer imunotherapy break-trough in lung cancer therapy?2020 | First Faculty of Medicine
- Prognostic significance of primary cilia in relation to selected parameters of the tumor microenvironment of clear cell renal cell carcinoma2020 | First Faculty of Medicine, Faculty of Physical Education and Sport, Third Faculty of Medicine
- Atezolizumab2018 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Immunotherapy in treatment of lung cancer2016 | Publication without faculty affiliation
- Metastatic melanoma - when and how it should by treated2016 | Publication without faculty affiliation
- Neuroendocrine lung tumors - current treatment options2018 | First Faculty of Medicine
- Immunotherapy of bronchogenic carcinoma and its perspectives2015 | Publication without faculty affiliation
- Nivolumab plus chemotherapy or ipilimumab in the first-line palliative therapy of esophageal, gastroesophageal junction, and gastric cancer2023 | Faculty of Medicine in Hradec Králové
- Complete response to pembrolizumab in a patient with stage IV NSCLC (non-small cell lung cancer)2020 | First Faculty of Medicine
- Autoimmune diabetes due to immunotherapy of malignant melanoma2020 | Second Faculty of Medicine
- Combined Cancer Immunotherapy Against Aurora Kinase A2016 | Faculty of Science
- Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis2022 | First Faculty of Medicine
- Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma2018 | First Faculty of Medicine